1,721,236 research outputs found
Vascular Behçet's disease: New insights in the management of thrombosis
No full textComment in
Thrombotic therapy in patients with Behçet's disease. [Expert Rev Cardiovasc Ther. 2014]
Anti-TNF-α agents in vascular Behçet's disease. [Expert Rev Cardiovasc Ther. 2014
Anti-TNF-α agents in vascular Behçet's disease
No full textComment on
Thrombotic therapy in patients with Behçet's disease. [Expert Rev Cardiovasc Ther. 2014]
Vascular Behçet's disease: new insights in the management of thrombosis. [Expert Rev Cardiovasc Ther. 2013
Dalla configurazione attuale alle fasi costruttive: storia dei cedimenti subiti dal Duomo di Modena
No full textDiagnostic Use of Laser Scanning Data to Identify Current and Historical Deformations and Geometries: the case of the Modena Cathedral
No full textThe paper describes the semi-automatic methodology to analyze the verticality and the horizontality of structural and architectural elements of the Modena cathedral with the aim to use real dataset to validate the new hypothesis about the history of contruction. moreover, the integration with the crack pattern allows to compute the current deformations of the monument
Behçet's disease as a cause of cerebral sinus vein thrombosis: an emerging role
No full textBehçet's disease as a cause of cerebral sinus vein thrombosis: an emerging role
Reply: anti-IL1 blocking agents in drug-resistant Behçet's syndrome: our little case series
No full textComment on
Efficacy of anakinra in refractory Behçet's disease sacroiliitis. [Clin Exp Rheumatol. 2014]
Anakinra for resistant Behçet uveitis: why not? [Clin Exp Rheumatol. 2013
Pharmacological prevention of venous thromboembolism in orthopaedic surgery
No full textThe prophylaxis of venous thromboembolism (VTE) with anticoagulant drugs is a long-established practice in hip and knee replacement surgery, as well as in the treatment of femoral neck fractures, while there are few data regarding the prevention of VTE in other fields of orthopaedic surgery and traumatology. In order to provide practical recommendations for daily management of VTE prophylaxis in orthopaedic patients, recently the Italian Societies of Thrombosis and Haemostasis, Orthopaedics and Traumatology and Anaesthesia have drawn up a first Intersociety Consensus on antithrombotic prophylaxis in total hip and knee replacement surgery, and in the treatment of femoral neck fracture, then updated in 2013, and a subsequent Intersocietary Consensus, in cooperation also with the Society of general practitioners, concerning antithrombotic prophylaxis in other types of orthopaedic surgery and traumatology. Before starting any prophylactic treatment it is of crucial importance the assessment of both thrombotic and bleeding risk of patients undergoing surgery. Thromboembolic prophylaxis is recommended with low molecular weight heparins (LMWH), fondaparinux (FON) or with the new oral anticoagulants (NOA) in patients undergoing hip and knee replacement surgery while patients undergoing treatment of femoral neck fracture should be treated with LMWH or FON. Regarding the non-prosthetic orthopaedic surgery and traumatology, it is recommended prophylaxis with LMWH or FON in situations of high thromboembolic risk or in the case of interventions or trauma involving pelvis, acetabulum or knee
- …
